| Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors (NCT00335491) | University of Utah | 2006-03-01 |
| Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer (NCT00334542) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2006-03-01 |
| Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer (NCT00332852) | Novartis Pharmaceuticals | 2006-03-01 |
| Capecitabine and Mitomycin C in Treatment of Patients With Metastatic Breast Cancer (NCT01196455) | Croatian Cooperative Group for Clinical Research in Oncology | 2006-03-01 |
| ROLL vs WGLL for Non-palpable Breast Lesions (NCT02869230) | Instituto Nacional de Cancerologia, Columbia | 2006-03-01 |
| Vibro-Acoustography Imaging in Diagnosing Breast Masses in Women With a Breast Mass or Breast Cancer (NCT00627614) | Mayo Clinic | 2006-03-01 |
| Mindfulness-based Stress Reduction in Breast Cancer Recovery (NCT00584142) | University of South Florida | 2006-03-01 |
| Effect of a Low Glycemic Index Diet on Breast Density (NCT01237938) | Roswell Park Cancer Institute | 2006-03-01 |
| Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone (NCT00458796) | University of Leeds | 2006-03-01 |
| Expanded Breast Cancer Registry and Tissue Repository (NCT00322894) | New Mexico Cancer Research Alliance | 2006-02-16 |
| Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer (NCT00258960) | Spanish Breast Cancer Research Group | 2006-02-15 |
| MRI in Evaluating Early Response to Chemotherapy in Women With Infiltrating Breast Cancer (NCT00462696) | Institut Bergonié | 2006-02-01 |
| Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients (NCT00303524) | AstraZeneca | 2006-02-01 |
| Phase 2 Study of Gemzar, Taxol & Avastin Combination as 1st Line Treatment for Metastatic Breast Cancer (NCT00403130) | George Albert Fisher | 2006-02-01 |
| 5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Treating Advanced Breast Cancer Patients (NCT00434369) | Mast Therapeutics, Inc. | 2006-02-01 |
| Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer (NCT00330317) | Novartis Pharmaceuticals | 2006-02-01 |
| Diet and Exercise or Normal Care in Overweight or Obese Women Who Have Undergone Treatment for Stage I, Stage II, or Stage III Breast Cancer (NCT00689975) | Sheffield Hallam University | 2006-02-01 |
| Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast Cancer (NCT00265733) | Alliance for Clinical Trials in Oncology | 2006-02-01 |
| Irinotecan and Cetuximab in Treating Patients With Metastatic Breast Cancer (NCT00275041) | Alliance for Clinical Trials in Oncology | 2006-02-01 |
| Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable or Locally Advanced Breast Cancer. (NCT00314977) | Radboud University Medical Center | 2006-02-01 |
| Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer (NCT00293540) | International Breast Cancer Research Foundation | 2006-02-01 |
| Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors (NCT00369109) | Barbara Ann Karmanos Cancer Institute | 2006-02-01 |
| D-cycloserine in the Management of Chemotherapy-Induced Peripheral Neuropathic Pain (NCT00301080) | Northwestern University | 2006-02-01 |
| Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer (NCT00320710) | Novartis Pharmaceuticals | 2006-02-01 |
| Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors (NCT00313599) | University of California, San Francisco | 2006-02-01 |
| A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Primary Breast Cancer (NCT02005549) | Hoffmann-La Roche | 2006-02-01 |
| The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer (NCT00444054) | Albert Einstein College of Medicine | 2006-02-01 |
| Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer (NCT00365599) | H. Lee Moffitt Cancer Center and Research Institute | 2006-02-01 |
| Trastuzumab and Oxaliplatin in Patients With Metastatic Breast Cancer (NCT00297596) | SCRI Development Innovations, LLC | 2006-02-01 |
| A Phase I Study of ECO-4601 in Patients With Advanced Cancer (NCT00338026) | Thallion Pharmaceuticals | 2006-02-01 |
| Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer (NCT00305643) | M.D. Anderson Cancer Center | 2006-02-01 |
| Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients With Invasive Breast Cancer (NCT00135018) | Organisation for Oncology and Translational Research | 2006-02-01 |
| The Efficacy and Safety of Pegylated Liposomal Doxorubicin Compared With Capecitabine as First Line Chemotherapy for Metastatic Breast Cancer (P04445/MK-2746-071) (NCT00266799) | Merck Sharp & Dohme LLC | 2006-01-13 |
| Vaccination With Autologous Breast Cancer Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Metastatic Breast Cancer Patients (NCT00317603) | Dana-Farber Cancer Institute | 2006-01-01 |
| Identification of a Screening Tool and Treatment of Lymphedema Secondary to the Management of Breast Cancer Study (NCT00282529) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2006-01-01 |
| Trivandrum Breast Cancer Screening Trial (NCT05301296) | International Agency for Research on Cancer | 2006-01-01 |
| Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer (NCT00288444) | Emory University | 2006-01-01 |
| Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast Cancer (NCT00379015) | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 2006-01-01 |
| Acupuncture for Anxiety in Women With Breast Cancer: A Feasibility Study (NCT00322504) | University of New Mexico | 2006-01-01 |
| Wound Infiltration and Breast Cancer Surgery (NCT01404377) | Tenon Hospital, Paris | 2006-01-01 |
| Diffusion Weighted MRI for Lymphnodes in the Axilla (NCT00276211) | Copenhagen University Hospital at Herlev | 2006-01-01 |
| A Study to Determine the Antitumor Activity and Evaluate the Safety of MKC-1 (NCT00306631) | CASI pharmaceuticals, Inc. | 2006-01-01 |
| Optical Spectroscopy During Breast Cancer Surgery and Core Needle Biopsy (NCT00734838) | Duke University | 2006-01-01 |
| Exercise Program or Health Education Program in Reducing Fatigue and Pain in Breast Cancer Survivors (NCT00336089) | Clayton State University | 2006-01-01 |
| Maintenance Treatment With Capecitabine Versus Observation in Breast Cancer Patients (NCT00130533) | Spanish Breast Cancer Research Group | 2006-01-01 |
| Clinical Trial of the Combination of Intravenous Alvespimycin (KOS-1022), Trastuzumab With or Without Paclitaxel in Patients With Advanced Solid Tumor Malignancies or Her2 Positive Metastatic Breast Cancer Who Have Previously Failed Trastuzumab Therapy (NCT00803556) | Bristol-Myers Squibb | 2006-01-01 |
| Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer (NCT00290758) | National Cancer Institute (NCI) | 2006-01-01 |
| PET-CT in the Initial Staging of Breast Cancer and in the Early Assessment of Response to Neoadjuvant Chemotherapy (NCT02599974) | Assistance Publique - Hôpitaux de Paris | 2006-01-01 |
| Trial of Myocet in Metastatic Breast Cancer (NCT00294996) | Sopherion Therapeutics | 2006-01-01 |
| Peptide Profiles of Women Undergoing Breast Biopsy (NCT00587821) | Memorial Sloan Kettering Cancer Center | 2006-01-01 |
| Metronomic Oral Vinorelbine in Patients With Metastatic Tumors (NCT00278070) | Hellenic Cooperative Oncology Group | 2006-01-01 |
| Role of Cytochrome P450 2D6 (CYP2D6) *4 Polymorphism,in Malignant Breast Diseases (NCT00539422) | Mansoura University | 2006-01-01 |
| Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer (NCT00265759) | Alliance for Clinical Trials in Oncology | 2006-01-01 |
| Clinical Outcomes in Hereditary Cancer (NCT00580021) | Memorial Sloan Kettering Cancer Center | 2006-01-01 |
| Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer (NCT00326820) | Wales Cancer Trials Unit | 2006-01-01 |
| RAPID: Randomized Trial of Accelerated Partial Breast Irradiation (NCT00282035) | Ontario Clinical Oncology Group (OCOG) | 2006-01-01 |
| AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer (NCT00310089) | National Cancer Institute (NCI) | 2006-01-01 |
| Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer (NCT00284180) | SCRI Development Innovations, LLC | 2006-01-01 |
| Radiation Therapy or Standard Therapy in Treating Women With Stage II Breast Cancer Who Have Undergone Mastectomy (NCT00966888) | Medical Research Council | 2006-01-01 |
| Studying Biopsy Samples in Women Undergoing First-Line Chemotherapy for Metastatic Breast Cancer (NCT00870168) | Centre Jean Perrin | 2006-01-01 |
| Caelyx Adjuvant in Elderly Breast Cancer (NCT00284336) | Universitaire Ziekenhuizen KU Leuven | 2006-01-01 |
| The Diagnostic Efficacy of Computer-Aided Detection (CAD) in Full-Field Digital Mammography (FFDM)- A Prospective Study (NCT00173303) | National Taiwan University Hospital | 2006-01-01 |
| Autologous Vaccination With Lethally Irradiated, Autologous Breast Cancer Cells Engineered to Secrete GM-CSF in Women With Operable Breast Cancer (NCT00880464) | Dana-Farber Cancer Institute | 2006-01-01 |
| Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery (NCT00424203) | UNICANCER | 2006-01-01 |
| Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer (NCT00648102) | Celldex Therapeutics | 2006-01-01 |
| Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer (NCT00897793) | Vanderbilt-Ingram Cancer Center | 2006-01-01 |
| Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery (NCT00301925) | Institute of Cancer Research, United Kingdom | 2005-12-16 |
| Trastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Trastuzumab (NCT00301899) | National Institutes of Health Clinical Center (CC) | 2005-12-01 |
| Erlotinib and Everolimus in Treating Patients With Metastatic Breast Cancer (NCT00574366) | Vanderbilt-Ingram Cancer Center | 2005-12-01 |
| Trastuzumab in Treating Women With Metastatic Breast Cancer (NCT00896376) | Centre Antoine Lacassagne | 2005-12-01 |
| Capecitabine Associated With Weekly Paclitaxel in Metastatic Breast Cancer. (NCT00270491) | ARCAGY/ GINECO GROUP | 2005-12-01 |
| Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey "Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)" (NCT02154139) | Takeda | 2005-12-01 |
| European Celecoxib Trial in Primary Breast Cancer (NCT02429427) | Imperial College London | 2005-12-01 |
| Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer (NCT00248170) | Novartis Pharmaceuticals | 2005-12-01 |
| ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer (NCT00261313) | Amgen | 2005-12-01 |
| CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer (NCT00270907) | M.D. Anderson Cancer Center | 2005-12-01 |
| Quality of Life in African-American or Caucasian Female Breast Cancer Survivors (NCT00268502) | Indiana University | 2005-12-01 |
| Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation (NCT00264420) | The Cleveland Clinic | 2005-12-01 |
| Clinical Trial of the Combination of Trastuzumab (Herceptin) and Tanespimycin in Patients With Solid Tumors and Her2 Positive Metastatic Breast Cancer That Have Previously Failed Herceptin (NCT00773344) | Bristol-Myers Squibb | 2005-12-01 |
| Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer (NCT00266110) | UNC Lineberger Comprehensive Cancer Center | 2005-12-01 |
| Vaccine Therapy in Treating Patients With Stage III or Stage IV Breast Cancer (NCT00304096) | University of Virginia | 2005-12-01 |
| Benefit of Adding Trastuzumab to Second Line Chemotherapy in Breast Cancer Patients Previously Treated With Trastuzumab (NCT00130507) | Spanish Breast Cancer Research Group | 2005-11-04 |
| Tamoxifen Pharmacokinetics and CYP2D6 Polymorphisms in Asian Women With Hormone Receptor Positive Breast Cancer (NCT00717015) | National University Hospital, Singapore | 2005-11-01 |
| Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer (NCT00245024) | National Cancer Institute (NCI) | 2005-11-01 |
| Effect of Increased Light Exposure on Fatigue in Breast Cancer (NCT00478257) | University of California, San Diego | 2005-11-01 |
| Adjunctive Efficacy Study Of The SoftScan® Optical Breast Imaging System (NCT00267449) | ART Advanced Research Technologies Inc. | 2005-11-01 |
| Lifemel Honey to Reduce Leucopenia During Chemotherapy (NCT00243165) | Rambam Health Care Campus | 2005-11-01 |
| Cetuximab + / - Carboplatin for Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer (NCT00232505) | UNC Lineberger Comprehensive Cancer Center | 2005-11-01 |
| Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy (NCT00542594) | AstraZeneca | 2005-11-01 |
| Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors (NCT00622674) | Masonic Cancer Center, University of Minnesota | 2005-11-01 |
| Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer (NCT00290732) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2005-11-01 |
| Phase 2 Study of Lovastatin as Breast Cancer Chemoprevention (NCT00285857) | Stanford University | 2005-11-01 |
| Safety and Rheumatologic Tolerability of Letrozole in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer (NCT00329940) | Novartis Pharmaceuticals | 2005-11-01 |
| RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer (NCT00253318) | M.D. Anderson Cancer Center | 2005-11-01 |
| OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer (NCT00258375) | NCIC Clinical Trials Group | 2005-10-21 |
| Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy (NCT00897299) | Eastern Cooperative Oncology Group | 2005-10-07 |
| Cellular Adoptive Immunotherapy in Treating a Patient Who Has Undergone a Donor Stem Cell Transplant for Breast Cancer That Has Spread to the Lung (NCT00301730) | National Cancer Institute (NCI) | 2005-10-01 |
| Effects of Hands-on-Healing vs. Touch for Fatigued Breast Cancer Survivors (NCT00440089) | University of California, San Diego | 2005-10-01 |
| Tamoxifen Citrate Decision Aids for Women at Increased Risk of Breast Cancer (NCT00967824) | University of Michigan Rogel Cancer Center | 2005-10-01 |
| The Safety and Efficacy of Zoledronic Acid in the Prevention of Cancer Therapy Induced Bone Loss (NCT00375505) | Novartis Pharmaceuticals | 2005-10-01 |